Is Defibrillation Testing Necessary for Implantable Transvenous Defibrillators?: Defibrillation Testing Should Not Be Routinely Performed at the Time of Implantable Cardioverter Defibrillator Implantation

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Circulation: Arrhythmia and Electrophysiology

• Publication date

  2014-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCEP.113.000373PMID 24736424
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of Fixed Tilt and Tuned Defibrillation Waveforms: The PROMISE Study

  2013cited by this paper
• No benefit of a dual coil over a single coil ICD lead: evidence from the Sudden Cardiac Death in Heart Failure Trial.

  2013cited by this paper
• How to Manage a High Defibrillation Threshold in ICD Patients: and Does it Really Matter?

  2013cited by this paper
• The rationale and design of the Shockless IMPLant Evaluation (SIMPLE) trial: a randomized, controlled trial of defibrillation testing at the time of defibrillator implantation.

  2012cited by this paper
• Reduction in inappropriate therapy and mortality through ICD programming.

  2012cited by this paper
• Clinical evaluation of defibrillation testing in an unselected population of 2,120 consecutive patients undergoing first implantable cardioverter-defibrillator implant.

  2012cited by this paper
• A Randomized‐Controlled Pilot Study Comparing ICD Implantation with and Without Intraoperative Defibrillation Testing in Patients with Heart Failure and Severe Left Ventricular Dysfunction: A Substudy of the RAFT Trial

  2012cited by this paper
• Azygous vein coil lowers defibrillation threshold in patients with high defibrillation threshold.

  2011cited by this paper
• Implantation of additional defibrillation lead into the coronary sinus: an effective method of decreasing defibrillation threshold.

  2011cited by this paper
• A rare cause of implantable cardioverter-defibrillator failure: short-circuiting via an unused pace/sense lead.

  2010cited by this paper
• Achieving low defibrillation thresholds at implant: pharmacological influences, RV coil polarity and position, SVC coil usage and positioning, pulse width settings, and the azygous vein

  2010cited by this paper
• Canadian Registry of ICD Implant Testing Procedures (CREDIT): Current Practice, Risks, and Costs of Intraoperative Defibrillation Testing

  2010cited by this paper
• Cardiac-resynchronization therapy for mild-to-moderate heart failure.

  2010cited by this paper
• Defibrillation Testing at the Time of ICD Insertion: An Analysis From the Ontario ICD Registry

  2010cited by this paper
• High defibrillation threshold in patients with implantable defibrillator: how effective is the subcutaneous finger lead?

  2009cited by this paper
• Defibrillation Threshold Testing: Tradition or Necessity?

  2009cited by this paper
• Complications associated with defibrillation threshold testing: the Canadian experience.

  2008cited by this paper
• Is Defibrillation Testing Still Necessary? A Decision Analysis and Markov Model

  2008cited by this paper
• Prognostic importance of defibrillator shocks in patients with heart failure.

  2008influential reference
• No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

  2008cited by this paper
• Defibrillation testing at the time of implantation of cardioverter defibrillator in the clinical practice: a nation-wide survey.

  2007cited by this paper
• Indications for predismissal testing with arrhythmia-induction in patients receiving an implantable cardioverter defibrillator

  2007cited by this paper
• The Dilemma of ICD Implant Testing

  2007cited by this paper
• Using the Upper Limit of Vulnerability to Assess Defibrillation Efficacy at Implantation of ICDs

  2007cited by this paper
• Effect of Amiodarone and Sotalol on Ventricular Defibrillation Threshold: The Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Trial

  2006cited by this paper
• Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation.

  2006cited by this paper
• Intraoperative Testing of the Implantable Cardioverter‐Defibrillator: How Much Is Enough?

  2006influential reference
• Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion?

  2005cited by this paper
• Appropriate and Inappropriate Ventricular Therapies, Quality of Life, and Mortality Among Primary and Secondary Prevention Implantable Cardioverter Defibrillator Patients: Results From the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) Trial

  2005cited by this paper
• Comparison of Step‐Down and Binary Search Algorithms for Determination of Defibrillation Threshold in Humans

  2004cited by this paper
• Is defibrillation testing required for defibrillator implantation?

  2004cited by this paper
• Efficacy and Temporal Stability of Reduced Safety Margins for Ventricular Defibrillation: Primary Results From the Low Energy Safety Study (LESS)

  2002cited by this paper
• Shock Reduction Using Antitachycardia Pacing for Spontaneous Rapid Ventricular Tachycardia in Patients With Coronary Artery Disease

  2001cited by this paper
• Randomized Cross‐Over Evaluation of Two Adaptive Pacing Algorithms for the Termination of Ventricular Tachycardia

  1993cited by this paper
• Improved low energy defibrillation efficacy in man with the use of a biphasic truncated exponential waveform.

  1989cited by this paper

• Noninvasive Impedance Analysis During S‐ICD Insertion Provides Justification for Defibrillation Based Testing Deferment

  2025cites this paper
• Patients with a high defibrillation threshold: Approaches to management

  2024cites this paper
• Teste de Limiar de Desfibrilação e Seguimento a Longo Prazo de Pacientes com Cardiopatia Crônica da Doença de Chagas

  2022cites this paper
• Defibrillation Threshold Testing and Long-term Follow-up in Chagas Disease

  2022cites this paper
• Single Coil Implantable Cardioverter Defibrillator Leads in Patients With Hypertrophic Cardiomyopathy.

  2020cites this paper
• Sedation in cardiac arrhythmias management

  2018cites this paper
• Effect of defibrillation threshold testing on effectiveness of the subcutaneous implantable cardioverter defibrillator

  2018cites this paper
• Characteristics and Outcomes of Pediatric Patients Who Undergo Placement of Implantable Cardioverter Defibrillators: Insights From the National Cardiovascular Data Registry

  2018cites this paper
• Defibrillation Threshold Testing: Current Status.

  2018cites this paper
• Clinical Review: Drugs and Devices

  2018cites this paper
• Defibrillation Testing During ICD Implantation - Should we or Should we Not?

  2017cites this paper
• 29 – Intraprocedural Assessment of Stimulation, Sensing, Detection, and Defibrillation

  2017cites this paper
• 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing

  2016cites this paper
• Reimplantation surgery in patients with implantable cardioverter defibrillators: A qualitative study.

  2016cites this paper
• 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.

  2016cites this paper
• 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.

  2016cites this paper
• sensus Statement on Optimal Implantable Cardioverter-Defibrillator Programming and Testing

  2015cites this paper